Clinical Trial Update: Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the dose-response of levalbuterol versus racemic albuterol to prevent exercise-induced bronchoconstriction in pediatric asthma patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Albuterol (racemic) (albuterol)
• Levalbuterol (Levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma, Bronchoconstriction | Phase 2 | Status: COMPLETED